_version_ 1797281592412995584
author Austin Jacobsen
Ying Huang
Natalie Hill
Karina Elias
Matthew Holman
Skyler Gordon
Nicole Foley
David Russler-Germain
Marcus Watkins
Eric D. Jacobsen
Alison Moskowitz
Amanda Cashen
Todd A. Fehniger
Brad Kahl
Armin Ghobadi
Beth Reagan
Anne Fischer
Fei Wan
Steven Horwitz
Neha Mehta-Shah
author_facet Austin Jacobsen
Ying Huang
Natalie Hill
Karina Elias
Matthew Holman
Skyler Gordon
Nicole Foley
David Russler-Germain
Marcus Watkins
Eric D. Jacobsen
Alison Moskowitz
Amanda Cashen
Todd A. Fehniger
Brad Kahl
Armin Ghobadi
Beth Reagan
Anne Fischer
Fei Wan
Steven Horwitz
Neha Mehta-Shah
author_sort Austin Jacobsen
collection DOAJ
first_indexed 2024-03-07T16:59:40Z
format Article
id doaj.art-0f6dc17d28ce4214bf4b37802314466d
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:59:40Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-0f6dc17d28ce4214bf4b37802314466d2024-03-03T03:25:31ZengWileyHemaSphere2572-92412023-08-017e01519ba10.1097/01.HS9.0000971624.01519.ba202308003-01080P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMAAustin Jacobsen0Ying Huang1Natalie Hill2Karina Elias3Matthew Holman4Skyler Gordon5Nicole Foley6David Russler-Germain7Marcus Watkins8Eric D. Jacobsen9Alison Moskowitz10Amanda Cashen11Todd A. Fehniger12Brad Kahl13Armin Ghobadi14Beth Reagan15Anne Fischer16Fei Wan17Steven Horwitz18Neha Mehta-Shah191 Invivoscribe Inc., San Diego, United States1 Invivoscribe Inc., San Diego, United States1 Invivoscribe Inc., San Diego, United States1 Invivoscribe Inc., San Diego, United States1 Invivoscribe Inc., San Diego, United States1 Invivoscribe Inc., San Diego, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States3 Dana-Farber Cancer Institute, Boston, United States4 Memorial Sloan Kettering Cancer Center, New York, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States2 Washington University School of Medicine, Saint Louis, United States4 Memorial Sloan Kettering Cancer Center, New York, United States2 Washington University School of Medicine, Saint Louis, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000971624.01519.ba
spellingShingle Austin Jacobsen
Ying Huang
Natalie Hill
Karina Elias
Matthew Holman
Skyler Gordon
Nicole Foley
David Russler-Germain
Marcus Watkins
Eric D. Jacobsen
Alison Moskowitz
Amanda Cashen
Todd A. Fehniger
Brad Kahl
Armin Ghobadi
Beth Reagan
Anne Fischer
Fei Wan
Steven Horwitz
Neha Mehta-Shah
P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
HemaSphere
title P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
title_full P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
title_fullStr P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
title_full_unstemmed P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
title_short P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
title_sort p1182 a prospective study of tcr measurable residual disease in peripheral t cell lymphoma
url http://journals.lww.com/10.1097/01.HS9.0000971624.01519.ba
work_keys_str_mv AT austinjacobsen p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT yinghuang p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT nataliehill p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT karinaelias p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT matthewholman p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT skylergordon p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT nicolefoley p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT davidrusslergermain p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT marcuswatkins p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT ericdjacobsen p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT alisonmoskowitz p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT amandacashen p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT toddafehniger p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT bradkahl p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT arminghobadi p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT bethreagan p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT annefischer p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT feiwan p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT stevenhorwitz p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma
AT nehamehtashah p1182aprospectivestudyoftcrmeasurableresidualdiseaseinperipheraltcelllymphoma